Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It …

Medical - Diagnostics & Research

US, Wilmington [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Charles River Laboratories International, Inc.'s gradings, price targets and earnings estimates. None

Earnings
Grading & Price

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	2.1500	2.700	1,165	1,156	102	110	169	247	151	155	225	261
2015	2.7200	3.712	1,297	1,358	126	145	203	292	177	199	269	319
2016	3.2100	4.467	1,363	1,656	149	142	230	346	206	218	300	380
2017	3.2900	5.133	1,681	1,854	154	114	292	344	237	261	367	374
2018	2.6000	5.925	1,857	2,253	123	205	368	463	287	300	373	460
2019	4.7200	6.554	2,266	2,613	226	238	410	531	331	332	443	577
2020	5.1700	7.858	2,621	2,889	252	285	563	597	351	334	517	429
2021	7.3500	10.265	2,923	3,522	364	364	768	751	432	545	528	568
2022	7.7700	10.890	3,540	3,911	390	454	820	883	589	679	619	587
2023	9.5700	10.592	3,976	4,106	486	431	986	971	650	747	665	645
2024	9.2700	10.005	4,129	3,992	474	514	1,032	963	617	657	747	720
2025	-	10.407	-	4,049	-	536	-	977	-	667	-	730
2026	-	11.696	-	4,298	-	618	-	1,037	-	708	-	775
2027	-	12.709	-	4,498	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	14.895	-	4,987	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141